Polθ is encoded by the gene POLQ. Polθ has become a therapeutic target of interest in cancers due to evidence of synthetic lethality when there is a loss of POLQ and dysregulation or loss of other DNA repair-related tumor suppressor genes that control double-strand break repair or HRR[20]. The gene discussed is POLQ; the disease is neoplasm.